For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260430:nRSd4785Ca&default-theme=true
RNS Number : 4785C Ashington Innovation PLC 30 April 2026
The information contained within this announcement is deemed by the Company to
constitute inside information stipulated under the Market Abuse Regulation
(EU) No. 596/2014, as retained as part of the law of England and Wales. Upon
the publication of this announcement via the Regulatory Information Service,
this inside information is now considered to be in the public domain.
Press Release
30 April 2026
Ashington Innovation plc
("Ashington" or "the Company")
Annual results
Ashington Innovation plc (LSE: ASHI; FSE: 6FW), a special purpose acquisition
company ("SPAC"), announces its audited results for the 12 months ended 31
December 2025.
Management report
Ashington Innovation plc was incorporated as a Special Purpose Acquisition
Vehicle (SPAC). The Company's objective remains that of generating an
attractive rate of return for its shareholders, predominantly through capital
appreciation, by taking advantage of opportunities to acquire companies or
businesses primarily in the technology sector and to operate those that it
acquires.
During the year under review, despite reviewing many potential opportunities,
both in the UK and overseas, and entering initial discussions with several of
them, as at the date of this Annual Report, the Company has not identified any
specific acquisition targets into which more detailed negotiations have been
entered. Initial discussions continue as the Company continues to actively
seek a suitable acquisition target, and the intention remains to acquire a
controlling interest in target business(es) or company(ies).
No revenue was generated during the year, and while the Company pursues its
long-term strategy to seek an acquisition target, it nevertheless needs to
fund the overheads associated with maintaining its status as a listed company.
The Directors continue to maintain a strict control over these running costs,
and the loss before tax of £199,094 has been considerably reduced from the
previous year's loss of £268,558.
The full annual report is available for download from the Company's website
(www.ashingtoninnovation.com).
For further information please contact:
Ashington Innovation PLC
Peter Presland info@ashingtoninnovation.com
Non-Executive Director
About Ashington Innovation plc
Ashington Innovation plc is a special purpose acquisition company (SPAC),
formed with the intention of acquiring businesses operating in the technology
sector, in particular the financial services technology and deep technology
sectors. The Company is not limited to any specific geographic region in
identifying its target companies. www.ashingtoninnovation.com.
Forward-looking statements:
This announcement may contain "forward-looking" statements and information
relating to the Company. These statements are based on the beliefs of Company
management, as well as assumptions made by and information currently available
to Company management. The Company does not undertake to update
forward‐looking statements or forward‐looking information, except as
required by law.
ASHINGTON INNOVATION PLC
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2025
Year ended 31 December Year ended 31 December
2025 (£) 2024 (£)
Administrative expenses (198,055) (268,751)
Finance income - 193
Finance charge (1,039) -
Loss before tax (199,094) (268,558)
Tax expense - -
Loss for the year (199,094) (268,558)
Total comprehensive income (199,094) (268,558)
Basic and diluted loss per share
Year ended 31 December 2025: (0.27p)
Year ended 31 December 2024: (0.37p)
There is no other comprehensive income. The loss for the year is the same as
the total comprehensive income for the year attributable to the owners of the
Company.
STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2025
Note 2025 (£) 2024 (£)
Assets
Current assets
Trade and other receivables 8 21,188 30,518
Cash and cash equivalents 16 50,565 185,810
Total assets 71,753 216,328
Liabilities
Current liabilities
Trade and other payables 9 51,693 48,213
Borrowings 10 104,923 68,230
Total liabilities 156,616 116,443
Net assets/(liabilities) (84,863) 99,885
Issued capital and reserves
Share capital 11 725,979 725,979
Share premium reserve 12 915,988 915,988
Retained earnings 12 (1,741,176) (1,542,082)
Other reserve 12 14,346 -
Total equity (84,863) 99,885
The financial statements were approved and authorised for issue by the board
of directors and were signed on its behalf by:
P E Presland
Director
29 April 2026
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2025
Share capital Share premium Retained earnings Other reserve Total equity
£ £ £ £ £
At 1 January 2024 625,979 815,998 (1,273,524) - 168,453
Comprehensive income for the year
Loss for the year - - (268,558) - (268,558)
Contributions by and distributions to owners
Issue of share capital, net of transaction costs 100,000 99,990 - - 199,990
(see Note 11 and Note 12)
At 1 January 2025 725,979 915,988 (1,542,082) - 99,885
Comprehensive income for the year
Loss for the year - - (199,094) - (199,094)
Contributions by and distributions to owners
Capital contribution on discounted loan - - - 14,346 14,346
At 31 December 2025 725,979 915,988 (1,741,176) 14,346 (84,863)
STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 DECEMBER 2025
Note 2025 (£) 2024 (£)
Cash flows from operating activities
Loss for the year (199,094) (268,558)
Adjustments for:
Movements in working capital:
Decrease / (Increase) in trade and other receivables 9,330 (8,549)
Increase / (Decrease) in trade and other payables 3,480 (99,419)
Net cash used in operating activities (186,284) (376,526)
Cash flows from financing activities
Issue of ordinary shares, net - 199,990
Increase in borrowings 10 51,039 39,200
Net cash from financing activities 35,654 239,190
Net (decrease) / increase in cash and cash equivalents (135,245) (137,336)
Cash and cash equivalents at beginning of year 185,810 323,146
Cash and cash equivalents at end of the year 16 50,565 185,810
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
1. General Information
Ashington Innovation PLC (the 'Company') is a public company incorporated in
England and Wales and domiciled in the United Kingdom. The Company's
registered office is at 27/28 Eastcastle Street, London, W1W 8DH.
The Company's principal activity is that of a Special Purpose Acquisition
Company.
These financial statements are presented in pounds sterling, which is the
Company's functional currency. All amounts have been rounded to the nearest
pound, unless otherwise indicated.
2. Material Accounting policies
2.1 Basis of preparation
The financial statements have been prepared in accordance with International
Financial Reporting Standards, International Accounting Standards and
Interpretations as adopted by the UK (collectively UK adopted IFRS) and those
parts of the Companies Act 2006 that are relevant to companies reporting in
accordance with UK adopted IFRS.
The financial statements have been prepared under the historical cost
convention unless otherwise specified within the accounting policies.
In preparing the financial statements, management made judgments, estimates
and assumptions that affect the application of the Company accounting policies
and the reported amounts of assets, liabilities, income and expenses. Actual
results may differ from these estimates.
Estimates and underlying assumptions are reviewed on an ongoing basis.
Revisions to estimates are recognised prospectively.
The Directors do not consider there to be any critical judgements that have
been made in arriving at the amounts recognised in the financial statements.
2.2 Going concern
As at 31 December 2025, the Company had cash at bank of £50,565 but made a
loss for the year ended at that date of £199,094 and has an accumulated
deficit on the statement of comprehensive income of £1,741,176. The Company
was established as a Special Purpose Acquisition Company and, as such is
unlikely to make any profit until the completion of a suitable acquisition.
During the previous year, the Company raised £199,990 net of costs through
the issue of new Ordinary shares to new investors, but the Directors recognise
that further funding is required under the Company's long-term plan to
continue to seek acquisition candidates. The Company has signed a loan
facility with its largest shareholder but also plans to raise significant
further equity capital either from existing or new investors. However, the
plans to raise additional equity capital from existing and new shareholders,
and the successful completion of a suitable acquisition are matters that are
not entirely within the control of the Directors and represent a material
uncertainty which may cast significant doubt on the Company's ability to
continue as a going concern. Despite this uncertainty, the loan facility the
Company has signed, has been increased and extended post year end. The
original loan facility of £200,000, as stated in Note 10 Borrowings, which
had a repayment term of 31 December 2026 has now been increased to £350,000
and the repayment term extended to 31 December 2027.
The Directors have a reasonable expectation that the Company has adequate
resources or access to further capital to continue in operational existence
for the foreseeable future and for this reason will continue to adopt the
going concern basis in the preparation of its financial statements.
2.3 Taxation
Income tax expense represents the sum of the tax currently payable and
deferred tax.
(i) Current tax
There is no tax payable as the Company has made a taxable loss for the year.
Taxable loss differs from 'Loss for the year' as reported in the statement of
comprehensive income because of items of income or expense that are taxable or
deductible in other years and items that are never taxable or deductible.
The Company's current tax liability would be ordinarily calculated using tax
rates that have been enacted or substantively enacted by the end of the
reporting period.
(ii) Deferred tax
Deferred tax liabilities are generally recognised for all taxable temporary
differences between accounting profits/ losses and taxable profits/ losses.
Deferred tax assets are generally recognised for all deductible temporary
differences to the extent that it is probable that future taxable profits will
be available against which those deductible temporary differences can be
utilised. Such deferred tax assets and liabilities are not recognised if the
temporary difference arises from the initial recognition (other than in a
business combination) of assets and liabilities in a transaction that affects
neither the taxable profit nor the accounting profit.
The measurement of deferred tax liabilities and assets reflects the tax
consequences that would follow from the manner in which the Company expects,
at the end of the reporting period, to recover or settle the carrying amount
of its assets and liabilities. The carrying amount of deferred tax assets is
reviewed at the end of each reporting period and reduced to the extent that it
is no longer probable that sufficient future taxable profits will be available
to allow all or part of the asset to be recovered.
Deferred tax liabilities and assets are calculated at the tax rates that are
expected to apply in the period in which the liability is settled or the asset
realised, based on tax rates (and tax laws) that have been enacted or
substantively enacted by the end of the reporting period.
(iii) Current and deferred tax for the period
Current and deferred tax are recognised in profit or loss, except when they
relate to items that are recognised in other comprehensive income or directly
in equity, in which case, the current and deferred tax are also recognised in
other comprehensive income or directly in equity respectively.
2.4 Cash and cash equivalents
Cash and cash equivalents comprise cash on hand and demand deposits, together
with other short-term, highly liquid investments maturing within 90 days from
the date of acquisition that are readily convertible into known amounts of
cash and which are subject to an insignificant risk of changes in value.
2.5 Financial instruments
Financial assets and financial liabilities are recognised when an entity
becomes a party to the contractual provisions of the instruments.
Financial assets and financial liabilities are initially measured at fair
value. Transaction costs that are directly attributable to the acquisition or
issue of financial assets and financial liabilities (other than financial
assets and financial liabilities at fair value through profit or loss) are
added to or deducted from the fair value of the financial assets or financial
liabilities, as appropriate, on initial recognition. Transaction costs
directly attributable to the acquisition of financial assets or financial
liabilities at fair value through profit or loss are recognised immediately in
profit or loss.
Financial liabilities including trade and other payables are non-interest
bearing and carried at the original invoice amount. Trade payables represent
obligations to pay for services that have been provided in the ordinary course
of business. All financial liabilities approximate to fair value due to the
short-term nature of the financial instruments.
Financial liabilities that are non-current and do not carry interest are
recognised at their fair value. Initially this is measured as the present
value of all future cash flows, discounted using the prevailing market
interest rates for a comparable instrument with a similar credit rating. For
shareholder loans, the difference between the cash received and the present
value is treated as a capital contribution and recorded in equity.
Subsequently the changes in fair value at each reporting date are recognised
in the statement of comprehensive income.
2.6 Share Capital and Share Premium
Ordinary shares are classified as equity and are carried at par value. Share
premium represents the excess money received for issued shares above the par
value, net of transaction costs.
2.7 Accumulated Deficit
Accumulated deficit is classified as equity and represents the accumulated
trading losses of the Company.
2.8 Share-based payments
The Company has issued warrants to initial investors and certain
counterparties and advisers.
Equity-settled share-based payments are measured at fair value (excluding the
effect of non-market-based vesting conditions) at the date of the grant,
equating to the end date the Company and counterparty had a shared
understanding of the terms and conditions of the agreement. The fair value so
determined is expensed on a straight-line basis over the vesting period, based
on the Company's estimate of the number of shares that will eventually vest
and adjusted for the effect of non-market-based vesting conditions.
2.9 Recently released Standards / Interpretations
The Company has resolved not to early adopt new or revised standards and
interpretations with an effective date after the date of these financial
statements. The Company intends to adopt these standards as soon as they
become effective.
The Company has applied the following amendments for the first time for their
annual reporting period commencing 01 January 2025:
· Lack of Exchangeability - Amendments to IAS 21 The Effects of Changes in
Foreign Exchange Rates
The Directors do not anticipate that the adoption of these new or revised
standards and interpretations will have a material impact on the Company's
financial statements in the period of initial application.
The following new standards, amendments to standards, and interpretations have
been issued, but are not effective for the reporting period commencing 01
January 2025 and have not been early adopted:
· 01 January 2026 - (Amendments to IFRS9 and IFRS 7) Amendments to
classification and measurement requirements for financial instruments
· 01 January 2027 - IFRS18 Presentation and Disclosure in Financial
Statements
· 01 January 2027 - (IFRS 19) Subsidiaries without Public Accountability:
Disclosures
The Directors do not believe the new and amended standards will have a
material effect on the Company.
2.10 Segmental reporting
As the Company operates as a single business unit with no activities that are
distinct reportable segments, then IFRS 8's segment reporting requirements do
not apply.
3. Auditor's remuneration
During the year, the Company obtained the following services from the
Company's auditors:
Year ended 31 December Year ended 31 December
2025 (£) 2024 (£)
Fees payable to the Company's auditors for the audit of the Company's 25,000 24,000
financial statements.
The auditor provided no non-audit services during the year or prior period.
4. Employee benefit expenses
Year ended 31 December Year ended 31 December
2025 (£) 2024 (£)
Employee benefit expenses (including directors) comprise:
Wages and salaries 18,000 18,000
National insurance 1,769 1,019
19,769 19,019
Key management personnel are those persons having authority and responsibility
for planning, directing and controlling the activities of the Company,
including the Directors of the Company listed on page 6.
Year ended 31 December Year ended 31 December
2025 (£) 2024 (£)
Salary and Employers National Insurance Contributions 19,769 19,019
19,769 19,019
The monthly average number of persons, including the Directors, employed by
the Company during the year was as follows:
Year ended 31 December Year end 31 December
2025 (No.) 2024 (No.)
Directors 5 5
5. Directors' remuneration
Year ended 31 December Year ended 31 December
2025 (£) 2024 (£)
Directors' emoluments 18,000 18,000
18,000 18,000
Directors' emoluments include salary and fees paid to Directors.
A breakdown of the remuneration paid to each Director who served during the
year is included within the Directors Remuneration Report on page 10, which
also provides details of share-based payments.
6. Tax expense
The reasons for the difference between the actual tax charge for the year and
the standard rate of corporation tax in the United Kingdom applied to losses
for the year are as follows:
Year ended 31 December Year ended 31 December
2025 (£) 2024 (£)
Loss for the year (199,094) (268,558)
Loss before income taxes (199,094) (268,558)
Tax using the Company's domestic tax rate of 25.00% (2024: 25%) (49,774) (67,140)
Unrelieved tax losses carried forward 49,774 67,140
Total current tax expense for the year - -
Factors affecting the current year tax charge
No liability to UK corporation tax arose on the ordinary activities for the
current period.
The Company has estimated excess management expenses of £1,739,978 (2024:
£1,540,884) available for carry forward against future trading profits.
The tax losses have resulted in a deferred tax asset at a rate of 25% (2024:
25%) of approximately £434,995 (2024: £385,221) which has not been
recognised in the financial statements due to the uncertainty of the
recoverability of the amount.
Changes in tax rates and factors affecting the future tax charges
There were no factors that may affect future tax charges.
The Company has assessed the impact of the Pillar Two model rules on its
financial statements. Based on the Company's current operations and tax
structure, the implementation of these rules does not have a material impact
on the Company's financial position, results of operations, or cash flows.
7. Earnings per share
Basic earnings per share
Basic loss per share is calculated by dividing the loss attributable to equity
shareholders by the weighted average number of Ordinary shares in issue during
the year:
Year ended 31 December Year ended 31 December
2025 2024
Loss after tax attributable to equity holders of the Company (£199,094) (£268,558)
Weighted average number of shares 72,597,900 72,597,900
Weighted average number of Ordinary shares on a diluted basis 72,597,900 72,597,900
Basic loss per share (0.27p) (0.37p)
For the financial year ended 31 December 2025 and the year ended 31 December
2024, basic loss per share and diluted loss per share are the same due to the
effect of warrants being non-dilutive in light of the loss per share.
8. Trade and other receivables
Year ended 31 December Year ended 31 December
2025 (£) 2024 (£)
Current
Prepayments and accrued income 17,720 23,201
VAT Recoverable 3,468 7,317
Total current trade and other receivables 21,188 30,518
9. Trade and other payables
Year ended 31 December As restated Year ended 31 December
2025 (£) 2024 (£)
Current
Trade payables 18,918 13,181
Accruals 32,775 35,032
Total current trade and other payables 51,693 116,443
As detailed in Note 18, Prior Year Reclassification, a previously categorised
other payable balance at 31 December 2024 has been recategorised within
borrowings and is disclosed in Note 10.
10. Borrowings
Year ended 31 December Year ended 31 December
2025 (£) 2024 (£)
Current
Discounted shareholder loan 104,923 68,230
Total current borrowings 104,923 68,230
In December 2025, the Company entered into a formal loan facility with a
Director, who was also a shareholder, for an amount of £200,000. During the
year, the amount loaned to the Company totalled £118,230 and the loan is
repayable on 31 December 2026.
The loan was recognised initially at its fair value of £103,884, which was
determined by discounting the future cash flows at a market rate of 12.0% per
annum. Subsequently, the loan was measured using the effective interest rate
method, and an interest charge recorded in the Statement of Comprehensive
Income.
The difference between the outstanding amount loaned of £118,230 and the fair
value on inception of the formalisation of the terms of the loan of £103,884,
which totals £14,346, was recognised as a capital contribution within 'Other
Reserves'. The increase in borrowings during the year was £51,039 as shown on
the Statement of Cash Flows and this consists of the movement shown above from
31 December 2024 to 31 December 2025 of £36,693 and the capital contribution
of £14,346.
Borrowings consist of transactions with related parties which are disclosed in
detail in Note 17.
11. Share capital
Issued and fully paid
Year ended 31 December Year ended 31 December Year ended 31 December Year ended 31 December
2025 Number 2025 £ 2024 Number 2024 £
Ordinary shares of £0.01 each
At start of the year 72,597,900 725,979 62,597,898 625,979
Issued in the year - - 10,000,002 100,000
At end of the year 72,597,900 725,979 72,597,900 725,979
During the prior year there were two new share issues.
10,000,000 Ordinary £0.01 shares were issued on 01 August 2024 and £0.02 was
paid per share.
2 Ordinary £0.01 shares were issued on 01 August 2024 and £0.01 was paid per
share.
The Ordinary Shares have attached to them full voting, dividend and capital
distribution (including on winding up) rights, they do not confer any rights
of redemption.
12. Reserves
Share premium
The share premium account is a non-distributable capital reserve that
represents the excess money received for issued shares above the par value,
net of transaction costs.
A premium of £99,990 was paid on shares issued during the prior year. At the
Balance Sheet date, the total cumulative share premium was £915,988.
Retained earnings
All reserves in respect of profit and loss are distributable reserves.
Other Reserve
This non-distributable reserve represents the discount element of an interest
free shareholder loan.
13. Financial instruments - fair values and risk management
Accounting classifications and fair values
The following table shows the carrying amounts of financial assets and
financial liabilities. It does not include fair value information for
financial assets and financial liabilities not measured at fair value if the
carrying amount approximates to fair value.
Year ended 31 December 2025 (£) Year ended 31 December 2024 (£)
Financial assets not measured at fair value
Cash and cash equivalents 50,565 185,810
50,565 185,810
Financial liabilities not measured at fair value
Trade and other payables 51,693 116,443
51,693 116,443
Financial liabilities measured at fair value
Borrowings 104,923 -
104,923 -
Financial Assets and Liabilities
Financial assets and liabilities are recognised on the Company's Statement of
Financial Position when the Company becomes party to the contractual
provisions of the instrument.
Financial risk management objectives
The Company's primary objective of financial risk management is to ensure
financial stability through the identification and assessment of financial
risks and developing suitable methods to mitigate these risks.
Credit Risk
The Company will only trade with third parties it recognises as being
creditworthy. Cash and cash equivalents are deposited only with a financial
institution that satisfy required credit criteria. There are no trade
receivable balances at the balance sheet date, but the Company will closely
monitor any future receivable balances to ensure such balances are fairly
stated.
Market risk
The Company's overall risk management programme considers the unpredictability
of financial markets and seeks to minimise potential adverse effects on the
Company's financial performance.
Liquidity risk
The Company has no borrowing that exposes it to liquidity risk. It closely
monitors liquid assets in the short term through the control and review of all
costs.
No maturity analysis has been prepared because there are no contractual
maturities and all trade payables will be due for payment within supplier
credit terms of 3 months or less.
Fair Values of Financial Assets and Liabilities
The Directors consider that the fair value of the Company's financial assets
and liabilities, other than borrowings, are not considered to be materially
different from their book values. Borrowings are initially recognised at their
fair value and subsequently the changes in fair value at each reporting date
are recognised in the statement of comprehensive income.
14. Controlling party
As at 31 December 2025 there is no ultimate controlling party.
15. Warrants
On 31 May 2023 the Company entered into an arrangement to issue warrants to
senior management, including the Directors, of the company. These warrants
will entitle the warrant holder to subscribe, following (and conditional upon)
completion of an acquisition, for such a number of Ordinary Shares as is
equal, in aggregate, to 5% of the number of new Ordinary Shares to be issued
as consideration shares pursuant to the acquisition at a subscription price of
£0.03 per share. These warrants will be exercisable for a period of two years
from the date of completion of the acquisition.
At the date of the warrant instrument being issued, the number of
consideration shares that will be issued following an acquisition is unknown
and therefore the number of shares subject to the warrants is unknown. The
timing of an acquisition is also unknown and therefore the expiry date of the
warrants is unknown. It is therefore not possible to disclose the number of
warrants outstanding or exercisable at the beginning nor end of the period nor
the weighted average remaining contractual life. No warrants were forfeited,
expired nor were exercised during the period.
As the warrants are to be settled in ordinary shares of the company, they have
been accounted for as an equity settled share-based payment in line with
IFRS2.
Given the number of unknown factors outlined above, the fair value of warrants
was determined by applying a Monte-Carlo simulation. The share-based payment
charge for the warrants has been taken in full at the date of the warrant
instrument being signed as there are no vesting conditions specified within
the warrant instrument.
A Monte Carlo simulation requires a number of assumptions to be made. The key
assumptions made to input into the Monte-Carlo simulation in respect of the
warrants are as follows:
Number of shares in issue at 31 May 2023 61,397,900
Period in which an acquisition is expected to occur 2 years
Probability of an acquisition within 2 years 66.67%
Minimum size of an acquisition £30,000,000
Maximum size of an acquisition £80,000,000
Probability distribution of the acquisition size Exponential
Number of warrant shares issued to satisfy the warrants 58,328,005
There were no changes to the warrants in issue or their terms. Accordingly,
the Company recognised £Nil (2024: £Nil) of expenditure related to the
warrants in the period.
16. Notes supporting statement of cash flows
31 December 2025 (£) 31 December 2024 (£)
Cash at bank available on demand 50,565 185,810
Cash and cash equivalents in the statement of financial position 50,565 185,810
Cash and cash equivalents in the statement of cash flows 50,565 185,810
17. Related Party Transactions
During the year the Company outsourced its administration services to
Mainvalley Limited, a Company owned and controlled by Peter Presland, a
Director of the Company. Mainvalley Limited charged the Company £18,000
(2024: £30,300) for these administration services.
At the Balance Sheet date, included within borrowings, was an amount owed of
£104,923 (2024: £68,230) to Jason Smart, a Director of the Company. The loan
to the Company, which is repayable on demand but not before 31 December 2026,
is interest free and unsecured, and forms part of a loan facility of £200,000
in total signed in December 2025. Upon formalisation of the repayment terms,
the other payable was recategorised as a borrowing liability.
18. Prior Year Reclassification
An existing payables balance, which was short-term, repayable on demand and
previously categorised as other payables at 31 December 2024, has been
recategorised within borrowings as at 31 December 2025 following the
formalisation of repayment terms and the Directors assessing a material change
in the nature of this balance during the year. As a result of this
reclassification, and in accordance with IAS1.41, the comparative balance of
£68,230 has been represented within borrowings. There has been no impact on
opening retained earnings as a result of this reclassification.
Effect on 2024 Financial Statements (Restated)
As Previously Reported Adjustments Restated
Statement of Financial Position
Trade and Other Payables 68,230 (68,230) -
Borrowings - 68,230 68,230
As Previously Reported Adjustments Restated
Statement of Cash Flows
Decrease in Trade and Other Payables (60,219) (39,200) (99,419)
Increase in Borrowings - 39,200 39,200
19. Unusual or Exceptional items
Included within the administrative expenses total for 2024 of £268,751 is a
credit in respect of VAT relating to prior period expenses of £84,317. The
Company was given a backdated VAT registration date of 01 June 2023; however,
this was not approved until 18 September 2024. As the approval date of the VAT
registration was after the date the 2023 financial statements were signed, all
expenses in the period ended 31 December 2023 were shown gross of VAT. The VAT
credit recognised in 2024 administrative expenses is considered an unusual
item in that it is a material non-recurring item.
20. Capital management and commitments
The Directors' objectives in capital management are to safeguard the Company's
ability to continue as a going concern in order to provide returns for the
shareholders and to maintain an optimal capital structure in order to reduce
the cost of capital. At the balance sheet date, the Company had been financed
by the introduction of capital as it was in the previous period. In the future
the expected capital structure of the Company is expected to consist of
borrowings and equity attributable to equity holders of the Company.
The Company is not currently subject to any externally imposed capital
requirements.
There was no capital expenditure contracted for at the end of the reporting
period but not yet incurred.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END FR VKLFLQZLXBBL
Copyright 2019 Regulatory News Service, all rights reserved